Recruiting
Phase 2

Diclofenac Sodium with Miconazole

Sponsor:

William N Handelman

Code:

NCT04341402

Conditions

Tinea Unguium, Onychomycosis

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Interventions

Antifungal Nail Gel Study

Study Details

Brief summary:

Study evaluates these take of diclofenac sodium when used in conjunction with miconazole and urea as a topical antifungal nail gel treatment for onychomycosis. All of the patient's will be treated with the active formula and blood levels of diclofenac sodium tested for as well as monitoring of hepatic and renal functions

Conditions

Tinea Unguium, Onychomycosis

Study ID

NCT04341402

Start date

May 1, 2020

Status verified date

Apr, 2020

Completion date

May 1, 2021

Anticipated

Primary completion date

Mar 31, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Male or female ≥ 21 years of age at Visit 1.
2. Not pregnant.
3. Stage 3 or lower Chronic Renal Failure.
4. PT/INR < 1.3 and not on anti-thrombotic; AST, ALT, Total Bilirubin WNL.
5. Documentation of a diagnosis of tinea unguium as evidenced by one or more clinical features consistent with the onychomycosis and one or more of the following criteria: KOH prep of the nail scrapings or positive culture of the nail scrapings; culture of nail with growth of any of the following Dermatophytes, non-dermatophytes or yeast.
6. TABLE 1 Epidermophyton floccosum Trichophyton mentagrophytes Trichophyton rubrum Acremonium Alternaria species Aspergillus species Botryodiplodia theobromae Fusarium species Onycochola canadensis Pyrenochaeta unguis-hominis Scytalidium dimidiatum scopulariopsis species Scytalidium hyalimum Candida albicans

Exclusion Criteria:

1. Chronic renal failure, chronic liver disease, alcoholism, pregnant, breastfeeding, or unwilling to practice birth control during participation in the study if of childbearing age..
2. Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
3. Concomitant use of any prescribed medication that may be adversely affected by diclofenac sodium.

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Experimental

miconazole 3% \& diclofenac sodium 1% \& urea 40% in topical gel daily for 6 months.

Interventions

Antifungal Nail Gel Study

Daily Application antifungal gel of miconazole 3% and diclofenac sodium 1% and urea 40% to infected nails.

Primary outcome measure

  • Diclofenac sodium serum levels [ Time Frame: 12 hours ]

Central Contacts and Locations

Central contacts

Locations

Bay Area Medical

Recruiting

Saint Petersburg, Florida, United States, 33710

Contacts

More Information

Sponsor

William N Handelman

Last update posted

Apr 10, 2020

Last verified

Apr, 2020

Keywords

  • Toenail fungus

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by William N Handelman on 2020-04-10.